Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2003
Baptista T., Ng Ying Kin N. M., Beaulieu S. (2003). Pharmacokinetic issues in the treatment of metabolic dysfunction induced by antipsychotic drugs, Clinical Pharmacokinetics , 43 (1 ), 1-16.
Maheu F. S., Beaulieu S., Lecours A. R., Lupien S. J. (2003). Memory for Emotional and Everyday Events: The Role of Noradrenaline and Cortisol, Brain Cogn , 51 , 226-227.